TIMOTHY SMITH: Open Payments
NPI 1306094198 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,974 in 206 payments from 16 companies in 2025. Trend: 2023 $2,692 · 2024 $6,398 · 2025 $5,974
Food & beverage: $4,705Consulting: $1,188Education: $82
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 10 | $1,287 |
| Novartis Pharmaceuticals Corporation | 55 | $824 |
| UCB, Inc. | 31 | $760 |
| GENZYME CORPORATION | 15 | $447 |
| ABBVIE INC. | 19 | $431 |
| Galderma Laboratories, L.P. | 19 | $401 |
| Organon LLC | 13 | $327 |
| Janssen Biotech, Inc. | 10 | $316 |
| Incyte Corporation | 7 | $303 |
| PFIZER INC. | 3 | $210 |
Products named: DUPIXENT, Bimzelx, TREMFYA, NEMLUVIO, COSENTYX, OPZELURA, VTAMA, SKYRIZI.
Industry payments across NY — which companies pay providers there.
